![Vijay Karwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vijay Karwal
Direktor/Vorstandsmitglied bei
MEGA LIFESCIENCES
Profil
Vijay Karwal is currently an Independent Director at Mega Lifesciences Public Co. Ltd. since 2021, Managing Director at CBC Group (Singapore) Pte.
Ltd. since 2024, Independent Non-Executive Director at OneSource Specialty Pharma Ltd. starting 2025, and Chief Financial Officer at AffaMed Therapeutics (HK) Ltd. since 2021.
Formerly, Mr. Karwal was Managing Director at Nomura International (Hong Kong) Ltd. from 2018 to 2021, Chief Development Officer at Davita, Inc. (Singapore) from 2016 to 2017, and worked at ABN AMRO Bank NV (Old) from 2004 to 2011.
Education includes graduate studies at the University of Groningen.
Aktive Positionen von Vijay Karwal
| Unternehmen | Position | Beginn |
|---|---|---|
| MEGA LIFESCIENCES | Direktor/Vorstandsmitglied | 13.05.2021 |
| ONESOURCE SPECIALTY PHARMA LIMITED | Direktor/Vorstandsmitglied | 27.02.2025 |
AffaMed Therapeutics (HK) Ltd.
 AffaMed Therapeutics (HK) Ltd. BiotechnologyHealth Technology Develops and commercializes ophthalmology, neurological and psychiatric products | Finanzdirektor/CFO | 01.05.2021 |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Private Equity Investor | 01.05.2021 |
Ehemalige bekannte Positionen von Vijay Karwal
| Unternehmen | Position | Ende |
|---|---|---|
Nomura International (Hong Kong) Ltd.
 Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.05.2021 |
Davita, Inc. (Singapore) | Corporate Officer/Principal | 01.11.2017 |
Ausbildung von Vijay Karwal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nomura International (Hong Kong) Ltd.
Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Mega Lifesciences Public Co. Ltd.
 Mega Lifesciences Public Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and trades health food supplements & pharmaceutical products | Health Technology |
OneSource Specialty Pharma Ltd.
 OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
AffaMed Therapeutics (HK) Ltd.
AffaMed Therapeutics (HK) Ltd. BiotechnologyHealth Technology Develops and commercializes ophthalmology, neurological and psychiatric products | Health Technology |
Davita, Inc. (Singapore) |
